XML 44 R30.htm IDEA: XBRL DOCUMENT v3.25.1
Net Loss Per Share of Common Stock (Tables)
3 Months Ended
Mar. 31, 2025
Earnings Per Share [Abstract]  
Schedule of Computation Basic and Diluted Earnings Per Share
The following table sets forth the computation of basic and diluted net loss per share for the three months ended March 31, 2025 and 2024 (in thousands, except share and per share amounts): For purposes of earnings per share, the Series B Convertible Preferred Stock have the same characteristics as common stock and have no liquidation or other material preferential rights over common stock and accordingly, have been considered as a second class of common stock in the computation of net loss per
share regardless of their legal form. Losses are allocated between the common stock and the Series B Convertible Preferred Stock on a pro rata basis as they share equally in losses and residual net assets on an as-converted basis.
Three months ended March 31,
20252024
Net loss
$(15,350)$(11,924)
Net loss attributable to common shareholders — basic and diluted$(15,350)$(11,899)
Weighted shares used in calculating net loss per common share — basic and diluted291,996,562 257,232,636 
Net loss per share attributable to common shareholders — basic and diluted$(0.05)$(0.05)
Net loss attributable to Series B Convertible Preferred shareholders — basic and diluted— (25)
Weighted shares used in calculating net loss per Series B Convertible Preferred Stock — basic and diluted— 54,745 
Net loss per share attributable to Series B Convertible Preferred shareholders — basic and diluted$— $(0.46)
Schedule of Potentially Dilutive Securities Excluded from Computation of Earnings Per Share
The following potentially dilutive securities have been excluded from the computation of diluted weighted average shares outstanding, as their inclusion would have been antidilutive:
Three months ended March 31,
20252024
Stock options to purchase common stock22,643,905 15,100,909 
RSUs948,862 2,027,107 
PSUs4,186,797 615,467 
Warrants628,664 628,834 
Series B Convertible Preferred Stock (as converted to common stock)— 547,450 
Total28,408,228 18,919,767